*NURSING > EXAM REVIEW > NR566 / NR 566 Advanced Pharmacology for Care of the Family Final Exam Week 5 Review (Graded A) Cham (All)

NR566 / NR 566 Advanced Pharmacology for Care of the Family Final Exam Week 5 Review (Graded A) Chamberlain College of Nursing

Document Content and Description Below

NR-566 Advanced Pharmacology for Care of the Family Final Exam Week 5 Review 1. What therapy and its dose is started within 48 hours of a TIA or ischemic stroke? - 2. Causes of sickling / S... ickle Cell crisis - 3. Iron Deficiency Anemia (IDA) - 4. Treatment of iron deficiency anemia - 5. Monitoring for Iron Deficiency Anemia treatment - 6. Patient Education: Iron Deficiency Anemia - 7. Pernicious Anemia (PA) - 8. Treatment of Pernicious Anemia (PA) - 9. Vit B12 dose for deficiency prevention - 10. Foods high in Vit B12 - prevent PA - 11. Patient Education: Pernicious anemia - 12. Anemia of chronic disease - 13. sickle cell anemia - 14. Folic acid deficiency anemia - 15. Drug therapy for folic acid deficiency anemia - 16. Folic acid prophylaxis - 17. Patient education: Folic Acid deficiency anemia - 18. Monitoring of folic acid deficiency - 19. Anemia with peripheral neuropathy is related to - 20. Sickle Cell Anemia - prophylaxis therapy for children - 21. Drug of choice to prevent and treat thromboembolism - 22. Titrate INR to this in order to prevent events listed - 23. Initial dose of warfarin - 24. Initial treat of upper or lower extremity DVT - 25. Preferred treatment of DVT - 26. How long do we treat DVT d/t a reversible risk factor? - 27. How many days of prophylaxis therapy is needed with fondaparinux or LMWH when a patient has superficial vein thrombosis in the lower limb that is greater than 5cm? - 28. What is the preferred drug (per ACCP) and dose when patient has superficial vein thrombosis in lower limb that is greater than 5cm? - 29. For patients with DVT or PE along WITH cancer, ACCP recommends LMWH for how long? - 30. Dose of apixaban to treat DVT & PE - 31. Dose of apixaban to reduce risk of further DVT & PE - 32. Patient education: Air travel >8 hours for patients at risk for DVT - 33. Patient education: All patients regarding DVT prevention - 34. ACCP Guidelines: Patients with AF and a low risk of stroke (CHADS2 score of 0), recommended therapy is: - 35. ACCP Guidelines: Patients with AF and intermediate risk of stroke (CHADS2 score of 1), recommended therapy is: - 36. ACCP Guidelines: Patients with AF and high risk of stroke (CHADS2 score of 2+), recommended therapy is: - 37. Drug of choice for recurrent embolism or a prosthetic heart valve? - 38. Long-term management of patients with bioprosthetic valves in SR are managed on - 39. BLACK BOX WARNING: Ticagrelor (Brillenta) - 40. BLACK BOX WARNING: Dabigatran (Pradaxa) - 41. BLACK BOX WARNING: Vorapaxar - 42. Antidote & dose for enoxaparin - 43. Antidote and dose for dalteparin and tinzaparin - 44. Antidote and dose for fondaparinux (Arixtra) - 45. Antidote and dose for Apixaban - 46. When to stop Tigrgrelor - 47. Treatment of Warfarin toxicity - 48. Herbals that increase bleeding with patients on warfarin are - 49. Herbals that decrease efficacy of warfarin are - 50. Due to the high incidence of drug interactions with warfarin, how often should INR be checked when adding new therapies? - 51. 3 long-term therapy options after non-cardioembolic ischemic stroke or TIA - 52. Treatment post PCI (with or without stent) in patients with ACS - 53. Warfarin monitoring - 54. Time of day for warfarin dose and testing - 55. What is the recommended increment of change (in percent) in warfarin dose to prevent wide swings in coagulation (unless INR is wildly out of range)? - 56. If the patient has a known genotype with CYP 2C9 or VKORC1 gene variant, what can you expect with warfarin therapy. - 57. Heparin monitoring - 58. LMWH monitoring - 59. Ticlopidine monitoring - 60. MMR--measles, mumps & rubella vaccine - 61. Oral Poliovirus Vaccine (OPV) - 62. Rotavirus vaccine - 63. Varicella Virus Vaccine - 64. Zoster Vaccine - 65. Diptheria, Tetanus, Pertussis - 66. Inactivated Polio Vaccine (IPV) - 67. Hepatitis B vaccine - 68. HPV vaccine - 69. Vaccines contraindicated during pregnancy - [Show More]

Last updated: 2 months ago

Preview 1 out of 10 pages

Add to cart

Instant download

Reviews( 0 )

$9.00

Add to cart

Instant download

Can't find what you want? Try our AI powered Search

OR

REQUEST DOCUMENT
865
7

Document information


Connected school, study & course


About the document


Uploaded On

Oct 08, 2020

Number of pages

10

Written in

Seller


seller-icon
quiz_bit

Member since 3 years

552 Documents Sold


Additional information

This document has been written for:

Uploaded

Oct 08, 2020

Downloads

 7

Views

 865

Recommended For You

Get more on EXAM REVIEW »
What is Browsegrades

In Browsegrades, a student can earn by offering help to other student. Students can help other students with materials by upploading their notes and earn money.

We are here to help

We're available through e-mail, Twitter, Facebook, and live chat.
 FAQ
 Questions? Leave a message!

Follow us on
 Twitter

Copyright © Browsegrades · High quality services·